From ultra-flexible materials redefining brain-computer interfaces (BCIs) to record-shattering global out-licensing deals, China’s biopharmaceutical sector is undergoing a profound qualitative transformation. ShanghaiEye takes you inside the Yunfan Future Factory and the cross-discipline innovation hub hosted by Chia Tai Tianqing (CTTQ)—a subsidiary of top-50 global pharma giant Sino Biopharmaceutical—to explore the cutting-edge ecosystem driving the future […]

Beyond Neuralink: How China’s Bio-Tech Breakthrough Fuels Next-Gen Brain-Computer Interfaces
Dan Breeden
